Andrew Morozov
Private Equity Investor chez CISCO SYSTEMS, INC.
Profil
Andrew Morozov is currently an Independent Director at CureLab Oncology, Inc., a Corporate Business Development & Investment Manager at Cisco Systems, Inc., and a Partner at Gauss Ventures Ltd.
He previously worked as a Principal at TL Ventures, Inc. from 2000 to 2004.
Dr. Morozov holds an MBA degree from The Wharton School of the University of Pennsylvania.
Postes actifs de Andrew Morozov
| Sociétés | Poste | Début |
|---|---|---|
| CISCO SYSTEMS, INC. | Private Equity Investor | - |
CureLab Oncology, Inc.
 CureLab Oncology, Inc. BiotechnologyHealth Technology Part of Curelab Veterinary, Inc., CureLab Oncology, Inc. is a pre-IPO, clinical-stage biotech company headquartered in the greater area. The company is based in Boston, MA. The company is dedicated to advancing new and safer therapeutics for solid tumors and other oncology and inflammatory indications. CureLab Oncology is developing an experimental DNA therapy called p62/sqstm1, which consists of a circular piece of DNA called a plasmid that includes a gene for a human protein. The company was founded by Alexander Shneider, who has been the CEO since incorporation. | Directeur/Membre du Conseil | - |
Gauss Ventures Ltd.
 Gauss Ventures Ltd. Investment ManagersFinance Gauss Ventures Ltd. (Gauss Ventures) is a venture capital firm, founded in 2017. It is headquartered in London. | Private Equity Investor | 01/02/2018 |
Anciens postes connus de Andrew Morozov
| Sociétés | Poste | Fin |
|---|---|---|
TL Ventures, Inc.
 TL Ventures, Inc. Investment ManagersFinance TL Ventures Inc (TL Ventures) is a venture capital subsidiary of Safeguard Scientifics, Inc. founded in 1988 by Robert Keith. The firm is headquartered in Wayne, Pennsylvania. | Private Equity Investor | 01/01/2004 |
Formation de Andrew Morozov
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CISCO SYSTEMS, INC. | Electronic Technology |
| Entreprise privées | 3 |
|---|---|
TL Ventures, Inc.
TL Ventures, Inc. Investment ManagersFinance TL Ventures Inc (TL Ventures) is a venture capital subsidiary of Safeguard Scientifics, Inc. founded in 1988 by Robert Keith. The firm is headquartered in Wayne, Pennsylvania. | Finance |
Gauss Ventures Ltd.
Gauss Ventures Ltd. Investment ManagersFinance Gauss Ventures Ltd. (Gauss Ventures) is a venture capital firm, founded in 2017. It is headquartered in London. | Finance |
CureLab Oncology, Inc.
CureLab Oncology, Inc. BiotechnologyHealth Technology Part of Curelab Veterinary, Inc., CureLab Oncology, Inc. is a pre-IPO, clinical-stage biotech company headquartered in the greater area. The company is based in Boston, MA. The company is dedicated to advancing new and safer therapeutics for solid tumors and other oncology and inflammatory indications. CureLab Oncology is developing an experimental DNA therapy called p62/sqstm1, which consists of a circular piece of DNA called a plasmid that includes a gene for a human protein. The company was founded by Alexander Shneider, who has been the CEO since incorporation. | Health Technology |
